Skip to main content

Find Clinical Trials

Home
Conditions
TDP-43 Proteinopathies

Clinical trial condition

TDP-43 Proteinopathies

Explore clinical trials studying TDP-43 Proteinopathies. Study availability and eligibility vary by location and protocol.

870 public trials 211 recruiting studies

Refine in advanced search Browse all conditions

TDP-43 Proteinopathies trial results

Completed

Effects of Nocturnal Non-invasive Ventilation in Patients With Amyotrophic Lateral Sclerosis

NCT00958048

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Hypoventilation, +15 more
Locations: Peilin Lee Taipei, Taiwan

View Trial Details

Completed

Trial of Early Noninvasive Ventilation for Amyotrophic Lateral Sclerosis (ALS)

NCT00580593

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations: University of Michigan Ann Arbor, Michigan, United States

View Trial Details

Completed

Levetiracetam for Cramps, Spasticity and Neuroprotection in Motor Neuron Disease

NCT00324454

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +22 more
Locations: Duke University ALS Clinic - 932 Morreene Road Durham, North Carolina, United States

View Trial Details

Completed

Efficacy and Tolerability of Memantine in Frontotemporal Dementia (FTD) Patients

NCT00200538

Conditions: Brain Diseases, Central Nervous System Diseases, Dementia, +10 more
Locations: Martine Vercelletto Nantes, France

View Trial Details

Completed

Comparing The Cyberlink Control System to the Manual Letter Board for Communication Purposes in the ALS Patient Population

NCT00718497

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +10 more
Locations: MDA/ALS Center of Hope Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Insulin-like Growth Factor-1 in Amyotrophic Lateral Sclerosis (ALS) Trial

NCT00035815

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations: Mayo Clinic in Scottsdale Scottsdale, Arizona, United States

California Pacific Medical Center San Francisco, California, United States

Mayo Clinic in Jacksonville Jacksonville, Florida, United States

Emory University Atlanta, Georgia, United States

View all 20 locations

View Trial Details

Completed

Combination Therapy in Amyotrophic Lateral Sclerosis (ALS)

NCT00919555

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations: Phoenix Neurological Associates, LTD Phoenix, Arizona, United States

View Trial Details

Completed

A Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)

NCT01281631

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations: Mayo Clinic, Scottsdale Scottsdale, Arizona, United States

UC, Irvine Irvine, California, United States

UCLA Los Angeles, California, United States

California Pacific Med Center Forbes Norris MDA/ALS Research and Treatment Center San Francisco, California, United States

View all 17 locations

View Trial Details

Completed

Neuromuscular Transmission in Amyotrophic Lateral Sclerosis

NCT00847847

Conditions: Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations: Bruneteau Gaelle Paris, France

View Trial Details

Completed

A 52 Week Open Label Trial of Memantine for Frontotemporal Lobar Degeneration

NCT00187525

Conditions: Brain Diseases, Central Nervous System Diseases, Dementia, +9 more
Locations: Not specified

View Trial Details